• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-arrestin 2 和 Epac2 协同介导 DRD1 刺激的人神经干细胞增殖和人脑类器官生长。

β-Arrestin 2 and Epac2 Cooperatively Mediate DRD1-Stimulated Proliferation of Human Neural Stem Cells and Growth of Human Cerebral Organoids.

机构信息

School of Life Science and Technology, Shanghai Tech University, Shanghai, People's Republic of China.

State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell, Science, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People's Republic of China.

出版信息

Stem Cells. 2022 Sep 26;40(9):857-869. doi: 10.1093/stmcls/sxac046.

DOI:10.1093/stmcls/sxac046
PMID:35772103
Abstract

G-protein-coupled receptors (GPCRs) reportedly relay specific signals, such as dopamine and serotonin, to regulate neurogenic processes although the underlying signaling pathways are not fully elucidated. Based on our previous work, which demonstrated dopamine receptor D1 (DRD1) effectively induces the proliferation of human neural stem cells, here we continued to show the knockout of β-arrestin 2 by CRISPR/Cas9 technology significantly weakened the DRD1-induced proliferation and neurosphere growth. Furthermore, inhibition of the downstream p38 MAPK by its specific inhibitors or small hairpin RNA mimicked the weakening effect of β-arrestin 2 knockout. In addition, blocking of Epac2, a PKA independent signal pathway, by its specific inhibitors or small hairpin RNA also significantly reduced DRD1-induced effects. Simultaneous inhibition of β-arrestin 2/p38 MAPK and Epac2 pathways nearly abolished the DRD1-stimulated neurogenesis, indicating the cooperative contribution of both pathways. Consistently, the expansion and folding of human cerebral organoids as stimulated by DRD1 were also mediated cooperatively by both β-arrestin 2/p38 MAPK and Epac2 pathways. Taken together, our results reveal that GPCRs apply at least 2 different signal pathways to regulate neurogenic processes in a delicate and balanced manners.

摘要

G 蛋白偶联受体(GPCRs)据报道能传递特定的信号,如多巴胺和血清素,以调节神经发生过程,尽管其潜在的信号通路尚未完全阐明。基于我们之前的工作,该工作表明多巴胺受体 D1(DRD1)能有效诱导人神经干细胞的增殖,在这里我们继续展示通过 CRISPR/Cas9 技术敲除β-arrestin 2 显著削弱了 DRD1 诱导的增殖和神经球生长。此外,通过其特异性抑制剂或短发夹 RNA 抑制下游 p38 MAPK 模拟了β-arrestin 2 敲除的削弱作用。此外,通过其特异性抑制剂或短发夹 RNA 阻断 Epac2(一种不依赖 PKA 的信号通路)也显著降低了 DRD1 诱导的作用。同时抑制β-arrestin 2/p38 MAPK 和 Epac2 通路几乎完全消除了 DRD1 刺激的神经发生,表明这两条通路的协同作用。一致地,DRD1 刺激的人大脑类器官的扩增和折叠也被β-arrestin 2/p38 MAPK 和 Epac2 通路协同介导。总之,我们的结果揭示了 GPCRs 至少应用 2 种不同的信号通路以精细和平衡的方式调节神经发生过程。

相似文献

1
β-Arrestin 2 and Epac2 Cooperatively Mediate DRD1-Stimulated Proliferation of Human Neural Stem Cells and Growth of Human Cerebral Organoids.β-arrestin 2 和 Epac2 协同介导 DRD1 刺激的人神经干细胞增殖和人脑类器官生长。
Stem Cells. 2022 Sep 26;40(9):857-869. doi: 10.1093/stmcls/sxac046.
2
Constitutive activity of a G protein-coupled receptor, DRD1, contributes to human cerebral organoid formation.一种 G 蛋白偶联受体(DRD1)的组成性活性有助于人类类器官的形成。
Stem Cells. 2020 May;38(5):653-665. doi: 10.1002/stem.3156. Epub 2020 Feb 18.
3
Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.血小板活化因子诱导的网格蛋白介导的内吞作用需要β-抑制蛋白-1在质膜上募集并激活p38丝裂原活化蛋白激酶信号体以形成肌动蛋白束。
J Immunol. 2006 Jun 1;176(11):7039-50. doi: 10.4049/jimmunol.176.11.7039.
4
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.β-抑制蛋白2依赖性1A型血管紧张素II受体介导的趋化作用途径。
Mol Pharmacol. 2005 Apr;67(4):1229-36. doi: 10.1124/mol.104.006270. Epub 2005 Jan 5.
5
β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10.β-抑制蛋白2通过靶向p38丝裂原活化蛋白激酶和白细胞介素10负向调节Toll样受体4(TLR4)触发的炎症信号传导。
J Biol Chem. 2014 Aug 15;289(33):23075-23085. doi: 10.1074/jbc.M114.591495. Epub 2014 Jul 10.
6
Structural basis of psychedelic LSD recognition at dopamine D receptor.致幻剂 LSD 在多巴胺 D 受体识别的结构基础。
Neuron. 2024 Oct 9;112(19):3295-3310.e8. doi: 10.1016/j.neuron.2024.07.003. Epub 2024 Aug 1.
7
Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.P 物质作为 MRGPRX2 的平衡激动剂,一个酪氨酸残基对于β-arrestin 的募集和受体内化是必需的。
Int J Mol Sci. 2021 May 18;22(10):5318. doi: 10.3390/ijms22105318.
8
Lack of beta-arrestin signaling in the absence of active G proteins.在缺乏活性G蛋白的情况下β-抑制蛋白信号缺失。
Nat Commun. 2018 Jan 23;9(1):341. doi: 10.1038/s41467-017-02661-3.
9
Dopamine receptor D1 signaling stimulates lipolysis and browning of white adipocytes.多巴胺受体 D1 信号刺激脂肪分解和白色脂肪棕色化。
Biochem Biophys Res Commun. 2022 Jan 15;588:83-89. doi: 10.1016/j.bbrc.2021.12.040. Epub 2021 Dec 18.
10
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.甲状旁腺激素受体刺激的ERK1/2激活存在不同的β-抑制蛋白和G蛋白依赖性途径。
J Biol Chem. 2006 Apr 21;281(16):10856-64. doi: 10.1074/jbc.M513380200. Epub 2006 Feb 21.

引用本文的文献

1
FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise.与骨靶向适配体偶联的富含FNDC5/鸢尾素的小细胞外囊泡可缓解骨质疏松症:一种潜在的运动替代方法
J Nanobiotechnology. 2025 Jul 12;23(1):504. doi: 10.1186/s12951-025-03587-5.
2
Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis.黄酮类化合物白杨素可激活TrkB和FGFR1受体,同时上调其内源性配体,如脑源性神经营养因子,以促进人类神经发生。
Cell Prolif. 2025 Jan;58(1):e13732. doi: 10.1111/cpr.13732. Epub 2024 Sep 27.
3
Alzheimer's Amyloid-β Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells.
阿尔茨海默病淀粉样β蛋白加速人神经干细胞衰老并抑制 SIRT1。
Biomolecules. 2024 Feb 4;14(2):189. doi: 10.3390/biom14020189.